NCT02561156View on ClinicalTrials.gov

TAK-653 Escalating Single and Multiple Dose Study in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

August 26, 2015

Primary Completion Date

September 11, 2017

Study Completion Date

September 23, 2017

Conditions
Depressive Disorder
Interventions
DRUG

TAK-653 Placebo

TAK-653 placebo-matching tablets.

DRUG

TAK-653

TAK-653 tablets.

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Neurocrine Biosciences

INDUSTRY